Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126627112 | 12662711 | 2 | F | 20160815 | 20160818 | 20160824 | EXP | US-TEVA-685910USA | TEVA | IRAGAVARAPU C, GUPTA T, CHUGH SS, ARONOW WS, FRISHMAN WH. TYPE B LACTIC ACIDOSIS ASSOCIATED WITH VENLAFAXINE OVERDOSE.AMERICAN JOURNAL OF THERAPEUTICS. 2016; 23(4):E1082-E1084 | 55.00 | YR | M | Y | 0.00000 | 20160824 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126627112 | 12662711 | 1 | PS | VENLAFAXINE | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | AROUND 80 EXTENDED-RELEASE CAPSULES OF VENLAFAXINE, THE TOTAL DOSE BEING APPROXIMATELY 6000 MG | 76690 | CAPSULE |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126627112 | 12662711 | OT |
| 126627112 | 12662711 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126627112 | 12662711 | Intentional overdose | |
| 126627112 | 12662711 | Lactic acidosis | |
| 126627112 | 12662711 | Suicide attempt |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |